Skip to Content

Chlorpheniramine / Hydrocodone Dosage

Medically reviewed on July 16, 2018.

Applies to the following strengths: 4 mg-5 mg; 8 mg-10 mg; 8 mg-10 mg/5 mL; 2 mg-2.5 mg/5 mL; 4 mg-5 mg/5 mL

Usual Adult Dose for Cold Symptoms

Immediate-release (IR): 5 mL orally every 4 to 6 hours as needed
Maximum dose: 20 mL in 24 hours
-Each 5 mL of IR oral solution contains hydrocodone bitartrate 5 mg with chlorpheniramine maleate 4 mg

Extended-release (ER): One dose orally every 12 hours
Maximum dose: 2 doses in 24 hours
-A dose equals 1 ER capsule or 5 mL ER suspension; each dose provides hydrocodone polistirex equivalent to 10 mg of hydrocodone bitartrate and chlorpheniramine polistirex equivalent to 8 mg chlorpheniramine maleate

Comments:
-Oral solution and suspension must be measured with an accurate milliliter measuring device; do not use a household teaspoon.

Use: For the symptomatic relief of cough and upper respiratory symptoms associated with allergy or a cold.

Usual Adult Dose for Cough

Immediate-release (IR): 5 mL orally every 4 to 6 hours as needed
Maximum dose: 20 mL in 24 hours
-Each 5 mL of IR oral solution contains hydrocodone bitartrate 5 mg with chlorpheniramine maleate 4 mg

Extended-release (ER): One dose orally every 12 hours
Maximum dose: 2 doses in 24 hours
-A dose equals 1 ER capsule or 5 mL ER suspension; each dose provides hydrocodone polistirex equivalent to 10 mg of hydrocodone bitartrate and chlorpheniramine polistirex equivalent to 8 mg chlorpheniramine maleate

Comments:
-Oral solution and suspension must be measured with an accurate milliliter measuring device; do not use a household teaspoon.

Use: For the symptomatic relief of cough and upper respiratory symptoms associated with allergy or a cold.

Renal Dose Adjustments

Severe renal impairment: Use with caution

Liver Dose Adjustments

Severe hepatic impairment: Use with caution

Dose Adjustments

Elderly: Use with caution

Precautions

US BOXED WARNING: RISKS FROM CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS:
-Concomitant use of opioids with benzodiazepines or other CNS depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. Avoid use of opioid cough medications in patients taking benzodiazepines, other CNS depressants, or alcohol.

Safety and efficacy of the immediate-release oral solution have not been established in patients younger than 18 years.

The US FDA recommends against use of hydrocodone-containing cough and cold medications in patients less than 18 years because it has been determined that the risks outweigh benefits.

Consult WARNINGS section for additional precautions.

US Controlled Substance: Schedule II (oral suspension/oral solution); Schedule III (oral capsules)

Dialysis

Data not available

Other Comments

Administration advice:
-Shake suspension well prior to measuring
-Measure oral solution and oral suspension with an accurate measuring device; a household teaspoon is not an accurate measuring device

General:
-Leading pediatric and pulmonary health organizations recommend against symptomatic treatment of cough in pediatric patients due to lack of efficacy studies and the possibility of significant morbidity and mortality; benefit to risk should be carefully considered in pediatric patients with respiratory compromise.
-The US FDA recommends against use of hydrocodone-containing cough and cold medications in patients less than 18 years because it has been determined that the risks outweigh benefits.

Monitoring:
-Monitor for the development of addiction, abuse, or misuse

Patient advice:
-Advise patients to store this drug safely out of the sight and reach of children; accidental use by a child is a medical emergency and can result in death.
-Patients should understand the risks of life-threatening respiratory depression, and should be informed as to when this risk is greatest.
-Women of child bearing potential should understand that prolonged opioid use during pregnancy can result in neonatal opioid withdrawal syndrome and that prompt recognition and treatment will be necessary; breastfeeding women should speak to their health care provider prior to using this drug.
-Patients should be instructed in proper disposal.
-Patients should not consume alcoholic beverages or take this drug with benzodiazepines or other CNS depressants; patients should avoid driving or operating machinery while taking this drug.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide